GCLC Human shRNA Plasmid Kit (Locus ID 2729)
CAT#: TR312813
GCLC - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 1 publication. |
Product images
经常一起买 (2)
GCLC mouse monoclonal antibody, clone OTI1A3 (formerly 1A3)
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | GCLC Human shRNA Plasmid Kit (Locus ID 2729) |
Locus ID | 2729 |
UniProt ID | P48506 |
Synonyms | GCL; GCS; GLCL; GLCLC |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | GCLC - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 2729). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | NM_001197115, NM_001498, NM_001498.1, NM_001498.2, NM_001498.3, NM_001197115.1, BC039894, BC022487, BC047788, NM_001498.4, NM_001197115.2 |
Summary | Glutamate-cysteine ligase, also known as gamma-glutamylcysteine synthetase is the first rate-limiting enzyme of glutathione synthesis. The enzyme consists of two subunits, a heavy catalytic subunit and a light regulatory subunit. This locus encodes the catalytic subunit, while the regulatory subunit is derived from a different gene located on chromosome 1p22-p21. Mutations at this locus have been associated with hemolytic anemia due to deficiency of gamma-glutamylcysteine synthetase and susceptibility to myocardial infarction.[provided by RefSeq, Oct 2010] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
EPITHELIAL AND MESENCHYMAL CELL BIOLOGY: Endogenous Hydrogen Peroxide Regulates Glutathione Redox via Nuclear Factor Erythroid 2-Related Factor 2 Downstream of Phosphatidylinositol 3-Kinase during Muscle Differentiation
,Yan Ding, Kyu Jin Choi, Jin Hwan Kim, Xuezhe Han, Yuji Piao, Jin-Hyun Jeong, Wonchae Choe, Insug Kang, Joohun Ha, Henry Jay Forman, Jinhwa Lee, Kyung-Sik Yoon, and Sung Soo Kim,
Am. J. Pathol., Jun 2008; 172: 1529 - 1541.
[GCLC]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...